Search Results - Kondagunta, G.V.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    4513 POSTER Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)

    4513 POSTER Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC) by Redman, B.G, Hudes, G.R, Kondagunta, G.V, Patel, P.H, Kim, S.T, Chen, I, Motzer, R.J

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    4520 POSTER Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study

    4520 POSTER Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study by Kondagunta, G.V, Hudes, G, Figlin, R, Wilding, G, Hariharan, S, Kempin, S, Fayyad, R, Hoosen, S, Motzer, R.J

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    65 POSTER Safety of Volociximab as a monotherapy and in combination with chemotherapy the result of three phase II studies

    65 POSTER Safety of Volociximab as a monotherapy and in combination with chemotherapy the result of three phase II studies by Yazji, S., Figlin, R.A., Kirkwood, J.M., Valle, J.W., Ramanathan, R.K., Bukowski, R.M., Bedikian, A.Y., Cranmer, L.D., Kondagunta, G.V., Evans, J.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: